Mr (or Ms) Lockstock - yes you are right: both that I did know it - and - that it is good of you to point it out for the reason you say. Thanks for highlighting it. I meant only the B cell suite.
(Just typing that makes me want a few more - the oncolytic virus could well eclipse it all and I also tend to forget about it a bit. The Vaxinia acquisition is like HER VAXX was when I first signed on: hopeful in models, yet to validate in people and something that the market seems to be assigning no value to.
Last little comment - what I have loved about how IMU has acquired it's extra lines is it's not been cash buying. IMU has 'merged tech': meaning IMU has faith in what it's acquiring and those selling have faith in what IMU had pre-merger. Sellers do not usually sell things for less than what they think they are worth - so I'm always wary of cash acquisitions.
Anyways, thanks Lockstock and go IMU!!
Imugene - Charts & Price Action (New thread), page-836
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |